Report Categories
View AllRecent Articles
View All
QGEN Qiagen falls 121 after Q4 2025 EPS narrowly misses Wall Street consensus estimates
Vertex Pharmaceuticals VRTX Robust Casgevy Early Launch Metrics Spark Counterintuitive Selloff for CoCommercialization Partner CRISPR Therapeutics
Illumina Inc ILMN Q1 2026 Earnings Preview Key Metrics Sector Context and Investor Expectations
CTAA EIDP Pref A latest quarterly earnings details remain undisclosed as the company finalizes public disclosure documents